When we determined CSF-NfL, a known marker for several neurodegenerative diseases, reflecting the neuroaxonal damage ( Holmberg et al., 1998 ; Petzold, 2005 ), we obtained a highly significant increase of NfL levels in patients with DLB and MSA compared to those with PD and controls.
← all excerpts
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies.
1
—
—